Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cero Therapeutics Has Received A Decision To Grant European Patent Number EP4376874 Titled "CHIMERIC TIM4 RECEPTORS AND USES THEREOF (FOR THE TREATMENT OF CANCER)"

Author: Benzinga Newsdesk | September 26, 2025 03:59pm

https://register.epo.org/application?number=EP22758100

Image

Posted In: CERO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist